GlassScriptPhysician profile
Andrew B Shaw
NPI 1437487709
$87,281.26
in general payments reported to CMS, 2019-2025
33 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,897 · 2020: $25K · 2021: $3,759 · 2022: $14K · 2023: $13K · 2024: $15K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Royalty Or License: $13K · Travel and Lodging: $8,804 · Food and Beverage: $1,696 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,875.00 |
| Royalty Or License | $13,009.72 |
| Travel and Lodging | $8,804.14 |
| Food and Beverage | $1,695.58 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $58,504.10 | 2019-2025 | Other - Miscellaneous, Battalion Tlif - PC, Invictus Mis |
| Hyhte Holdings INC. | $22,755.07 | 2020 | |
| Medtronic, INC. | $3,852.39 | 2021-2024 | Intellis Adaptivestim |
| Medtronic USA, INC. | $507.56 | 2019-2020 | |
| Boston Scientific Corporation | $320.11 | 2019-2024 | Wavewriter Alpha Prime 16, Bionic Navigator |
| Carlsmed, INC. | $182.18 | 2025 | Aprevo |
| Ebi, LLC | $134.32 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Nevro Corp. | $132.24 | 2020 | |
| Globus Medical, INC. | $130.23 | 2019-2025 | Excelsiusgps Robotic Navigation System, Senza |
| Relievant Medsystems, INC. | $129.09 | 2021 | |
| Stimwave Technologies Incorporated | $88.00 | 2021 | |
| Abbott Laboratories | $74.03 | 2019-2022 | |
| Biocomposites INC | $58.97 | 2025 | Stimulan |
| Surgical Theater. INC. | $48.78 | 2023 | |
| Zimmer Biomet Holdings, INC. | $37.63 | 2023 | Neuro Plating System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $31.99 | 2025 | Evoke |
| Innovation Technologies INC | $29.72 | 2025 | Irrisept |
| Portola Pharmaceuticals, LLC | $26.14 | 2019 | |
| Axogen | $26.13 | 2022 | |
| Highridge Medical LLC | $25.81 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Depuy Synthes Sales INC. | $23.72 | 2021 | |
| Olympus America INC. | $23.56 | 2023 | Olympus |
| Bioventus LLC | $20.37 | 2023 | Bonescalpel |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Arteriocyte Medical Systems, INC. | $17.77 | 2022 | |
| Irras USA, INC. | $15.80 | 2021 | |
| Smith+Nephew, INC. | $14.09 | 2022 | |
| Theragen, INC. | $13.76 | 2022 | |
| Silk Road Medical, INC. | $13.40 | 2021 | |
| Ethicon US, LLC | $12.82 | 2021 | |
| Brainlab, INC. | $11.48 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.